Excitatory Pathway Engaging Glutamate, Calcineurin, and NFAT Upregulates IL-4 in Ischemic Neurons to Polarize Microglia
Overview
Endocrinology
Neurology
Affiliations
Excitotoxicity and microglia/macrophage over-activation are the important pathogenic steps in brain damage caused by ischemic stroke. Recent studies from our group suggest that the neurons in ischemic penumbra generate an anti-inflammatory cytokine, interleukin-4 (IL-4). This neuron-produced IL-4 could subsequently convert surrounding microglia/macrophages to a reparative (M2)-phenotype. The present study was designed to establish the mechanisms by which neurons under transient ischemic condition produce/secrete IL-4. We employed primary rat cortical neurons and a validated in vitro ischemic injury model involving transient oxygen-glucose deprivation (OGD). We discovered that only sublethal OGD induces IL-4 production/secretion by neurons. We then showed that excitotoxic stimulus (an integral component of OGD-mediated damage) involving N-methyl-D-aspartate (NMDA), and not kainate receptor, triggers neuronal IL-4 production/release. Of note, oxidative stress or pro-apoptotic stimuli did not induce IL-4 production by neurons. Next, using the calcineurin inhibitor FK506, we implicated this phosphatase in activation of the nuclear factor of activated T-cells (NFAT; a transcription factor activated through calcineurin-mediated dephosphorylation) and propose that this pathway is involved in transcriptional upregulation of the IL-4 synthesis in NMDA-treated neurons. Finally, using a transfer of culture medium from NMDA-conditioned neuron to microglia, we showed that the neuronal IL-4 can polarize microglia toward a restorative, phagocytic phenotype.
Calcineurin inhibition may prevent Alzheimer disease in people with Down syndrome.
Dohl J, Treadwell Z, Norris C, Head E Alzheimers Dement. 2025; 21(3):e70034.
PMID: 40042516 PMC: 11881635. DOI: 10.1002/alz.70034.
Xu Y, Shao N, Zhi F, Chen R, Yang Y, Li J Alzheimers Res Ther. 2025; 17(1):35.
PMID: 39893485 PMC: 11786345. DOI: 10.1186/s13195-025-01682-1.
Ferreira P, Lebre C, Costa J, Amaral F, Ferreira R, Martinho F J Neurochem. 2024; 169(1):e16266.
PMID: 39676699 PMC: 11647562. DOI: 10.1111/jnc.16266.
Berner J, Acharjee A Discov Ment Health. 2024; 4(1):12.
PMID: 38630417 PMC: 11024073. DOI: 10.1007/s44192-024-00066-5.
Targeting CaN/NFAT in Alzheimer's brain degeneration.
Mackiewicz J, Lisek M, Boczek T Front Immunol. 2023; 14:1281882.
PMID: 38077352 PMC: 10701682. DOI: 10.3389/fimmu.2023.1281882.